Kindred Biosciences Overview

  • Founded
  • 2012
Founded
  • Status
  • Public
  • Employees
  • 63
Employees
  • Stock Symbol
  • KIN
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $9.19
  • (As of Friday Closing)

Kindred Biosciences General Information

Description

Kindred Biosciences Inc is a biopharmaceutical company developing innovative biologics focused on saving and improving the lives of pets. The company identifies targets that have already demonstrated safety and efficacy in humans and develop therapeutics based on these validated targets for dogs and cats. It has a pipeline of novel biologics in development across many therapeutic classes, alongside biologics manufacturing capabilities and a broad intellectual property portfolio.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Stock Exchange
NAS
Primary Office
  • 1555 Bayshore Highway
  • Suite 200
  • Burlingame, CA 94010
  • United States
+1 (888) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Kindred Biosciences Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$9.19 $9.19 $3.20 - $9.28 $417M 45.3M 1.09M -$0.21

Kindred Biosciences Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 170,997 131,169 264,776 279,723
Revenue 43,956 42,164 4,256 1,966
EBITDA (1,919) (15,292) (60,028) (50,451)
Net Income (8,775) (21,796) (61,389) (49,690)
Total Assets 109,979 95,814 114,024 106,482
Total Debt 23,301 23,372 22,523 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Kindred Biosciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kindred Biosciences‘s full profile, request access.

Request a free trial

Kindred Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Kindred Biosciences‘s full profile, request access.

Request a free trial

Kindred Biosciences Executive Team (7)

Name Title Board Seat Contact Info
Richard Chin MD Co-Founder, Chief Executive Officer & Board Member
Wendy Wee Chief Financial Officer, Finance & Secretary, Administration
Hangjun Zhan Ph.D Chief Scientific Officer
Katja Buhrer Chief of Staff, Vice President, Corporate Development and Investor Relations
You’re viewing 4 of 7 executive team members. Get the full list »

Kindred Biosciences Board Members (8)

Name Representing Role Since
Denise Bevers Kindred Biosciences Co-Founder & Board Member 000 0000
Ernest Mario Ph.D Self Board Member 000 0000
Ervin Veszprémi Kindred Biosciences Board of Director 000 0000
Joseph McCracken Self Board Member 000 0000
Raymond Townsend Self Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Kindred Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kindred Biosciences Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 0000000 21-Jun-2017 000000000 00000 00 00.000 Buildings and Property 000000 000000
To view Kindred Biosciences’s complete investments history, request access »